Bioventus Files for IPO
Bioventus Inc. filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. There were no pricing details given in the filing but the offering is valued up to…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 206
Lipocine Crashes After Receiving CRL From the FDA
Lipocine Inc. (NASDAQ: LPCN) is watching its shares get cut in half in Wednesday’s session after receiving a letter from the U.S. Food and Drug Administration (FDA). The company announced that it has received…
Is Galena Dead in the Water After This Failed Trial?
Galena Biopharma, Inc. (NASDAQ: GALE) is absolutely crashing on Wednesday after the company released further information regarding its Breast Cancer clinical trial. The company announced the recommendation from the Independent Data Monitoring Committee (IDMC)…
Eli Lilly Rises on Positive FDA Committee Vote
Eli Lilly and Co. (NYSE: LLY) is watching its shares make a decent gain on Wednesday following a U.S. Food and Drug Administration (FDA) vote. The FDA Advisory Committee voted 12-11 that substantial evidence…
Why Tesaro Is Skyrocketing
Tesaro, Inc. (NASDAQ: TSRO) is watching its shares make a significant gain on Wednesday after the company released positive late-stage trial results. The company announced that its Phase 3 NOVA trial of niraparib successfully…
5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero
Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently be the case in the largest stocks in the biotech sector within health care if RBC Capital Markets…
inVentiv Updates IPO Filing
inVentiv Group Holdings filed an amended Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were mentioned in this filing, but in the previous…
Why Regulus Is Tanking
Regulus Therapeutics Inc. (NASDAQ: RGLS) saw its shares cut in half early Tuesday morning following news of a clinical hold from the U.S. Food and Drug Administration (FDA). The company announced it received verbal…
DENTSPLY Slides on Acquisition News
DENTSPLY International Inc. (NASDAQ: XRAY) saw its shares pull back slightly in Monday’s session following news of an acquisition. The company announced a definitive agreement to acquire all of the outstanding shares of privately…
Medtronic Moves to Acquire Heartware
Heartware International (NASDAQ: HTWR) is watching its shares absolutely skyrocket in Monday’s session despite the huge market downturn from the Brexit. This surge is the result of Medtronic PLC (NYSE: MDT) moving to acquire…
Medpace Files for IPO
Medpace Holdings, Inc. filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). There were no pricing details mentioned in the filing but the offering is valued up…
Short Sellers Increase Bets Against Major Pharmaceutical Stocks
The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is…
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. After all, a cure or…
J.P. Morgan Very Positive on 3 Battered Specialty Pharmaceutical Stocks
Ever since the infamous Hillary Clinton tweet about pharmaceutical drug pricing, the biotech and specialty pharmaceutical stocks have taken a huge beating. In some cases, the markets have knocked valuations down into almost value…
A Biotech and a Medical Device Stock, Each With Massive Upside Potential
Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to be huge, but that have both been absolutely hammered over the past year.